Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits
- PMID: 458563
- DOI: 10.1002/jps.2600680606
Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits
Abstract
The low ocular bioavailability of topically applied pilocarpine is attributed to extensive precorneal drug loss in conjection with the resistance to corneal penetration. Several elements of precorneal loss were reported earlier, but a complete mechanistic understanding has not been available. The present study was designed to gain a better understanding of the mechanisms governing pilocarpine disposition in the precorneal areas as well as the relative influence of these parameters on ocular drug bioavailability. Radioactive pilocarpine and glycerin solutions were instilled into the precorneal area of the albino rabbit eye under various experimental conditions, and the drug concentration in the lacrimal lake was monitored as a function of time. The results demonstrated that nonconjunctival loss of pilocarpine, vasodilation due to the drug, and lacrimation due to vehicle formulation are additional aspects of precorneal drug disposition. The individual influence of all precorneal loss parameters on drug bioavailability was then assessed using a mathematical model formulated from experimental findings on both precorneal and intraocular drug disposition. Drainage and vasodilation, as well as nonconjunctival pilocarpine loss, exerted major influences on drug loss at the absorption site.
Similar articles
-
Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes.J Pharm Sci. 1976 Sep;65(9):1295-301. doi: 10.1002/jps.2600650909. J Pharm Sci. 1976. PMID: 966141
-
Concentration-dependent precorneal loss of pilocarpine in rabbit eyes.Acta Ophthalmol (Copenh). 1985 Oct;63(5):502-6. doi: 10.1111/j.1755-3768.1985.tb05235.x. Acta Ophthalmol (Copenh). 1985. PMID: 4072629
-
Quantitative evaluation of topically applied pilocarpine in the precorneal area.J Pharm Sci. 1984 Feb;73(2):219-22. doi: 10.1002/jps.2600730219. J Pharm Sci. 1984. PMID: 6707887
-
Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.Adv Colloid Interface Sci. 2016 Jul;233:139-154. doi: 10.1016/j.cis.2015.08.002. Epub 2015 Aug 14. Adv Colloid Interface Sci. 2016. PMID: 26318359 Review.
-
Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs.Curr Drug Metab. 2007 Feb;8(2):91-107. doi: 10.2174/138920007779815977. Curr Drug Metab. 2007. PMID: 17305490 Review.
Cited by
-
Ocular drug delivery. Pharmacokinetic considerations.Clin Pharmacokinet. 1990 Apr;18(4):255-69. doi: 10.2165/00003088-199018040-00001. Clin Pharmacokinet. 1990. PMID: 2182264 Review. No abstract available.
-
Microemulsion: new insights into the ocular drug delivery.ISRN Pharm. 2013 Jun 27;2013:826798. doi: 10.1155/2013/826798. Print 2013. ISRN Pharm. 2013. PMID: 23936681 Free PMC article.
-
Controlled delivery of pilocarpine. 1. In vitro characterization of Gelfoam matrices.Pharm Res. 1993 Jan;10(1):109-12. doi: 10.1023/a:1018985332376. Pharm Res. 1993. PMID: 8430046
-
Nanotherapy for Neural Retinal Regeneration.Adv Sci (Weinh). 2025 Jun;12(24):e2409854. doi: 10.1002/advs.202409854. Epub 2025 Jan 14. Adv Sci (Weinh). 2025. PMID: 39807033 Free PMC article. Review.
-
Advances in the use of prodrugs for drug delivery to the eye.Expert Opin Drug Deliv. 2017 Jan;14(1):49-63. doi: 10.1080/17425247.2016.1208649. Epub 2016 Jul 21. Expert Opin Drug Deliv. 2017. PMID: 27441817 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources